Bank of Montreal Can Raises Stock Position in DaVita Inc. (NYSE:DVA)

Bank of Montreal Can increased its holdings in shares of DaVita Inc. (NYSE:DVA) by 0.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 60,929 shares of the company’s stock after purchasing an additional 520 shares during the period. Bank of Montreal Can owned 0.07% of DaVita worth $9,936,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Transcendent Capital Group LLC acquired a new stake in shares of DaVita in the third quarter valued at about $25,000. Blue Trust Inc. grew its position in DaVita by 58.6% in the second quarter. Blue Trust Inc. now owns 211 shares of the company’s stock valued at $29,000 after acquiring an additional 78 shares in the last quarter. Family Firm Inc. purchased a new stake in shares of DaVita during the second quarter valued at approximately $43,000. Versant Capital Management Inc lifted its position in shares of DaVita by 90.6% during the second quarter. Versant Capital Management Inc now owns 326 shares of the company’s stock worth $45,000 after purchasing an additional 155 shares in the last quarter. Finally, Friedenthal Financial purchased a new position in shares of DaVita in the second quarter valued at $48,000. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at DaVita

In other news, CEO Javier Rodriguez sold 50,000 shares of the company’s stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the completion of the transaction, the chief executive officer now directly owns 837,835 shares of the company’s stock, valued at approximately $138,284,666.75. This represents a 5.63 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.00% of the company’s stock.

Analyst Ratings Changes

DVA has been the topic of a number of recent analyst reports. Truist Financial boosted their price objective on shares of DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a report on Monday, October 7th. UBS Group increased their price target on DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Barclays lifted their price objective on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a report on Thursday, October 31st. Finally, Bank of America increased their target price on DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a research note on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $161.80.

DaVita Trading Up 0.3 %

Shares of NYSE DVA opened at $166.17 on Monday. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78. The stock’s 50 day moving average price is $158.57 and its two-hundred day moving average price is $149.39. DaVita Inc. has a 52-week low of $99.18 and a 52-week high of $169.51. The stock has a market capitalization of $13.63 billion, a P/E ratio of 17.93, a PEG ratio of 0.94 and a beta of 0.89.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.76 by ($0.17). The firm had revenue of $3.26 billion for the quarter, compared to analyst estimates of $3.25 billion. DaVita had a net margin of 6.53% and a return on equity of 88.18%. The business’s revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the company posted $2.85 earnings per share. On average, analysts anticipate that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.